According to the SEC Form 4 filings, Mulay James, being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $3,701,938 | 5 | 100 |
| 2026-07-10 | Sale | CG Oncology Inc. CGON | director | 24,165 0.0274% | $75.16 | $1.82M | -4.51% | |
| 2026-06-15 | Sale | CG Oncology, Inc. Common stock CGON | director | 1,310 0.0015% | $60.12 | $78,757 | +19.72% | |
| 2026-04-17 | Sale | CG Oncology, Inc. Common stock CGON | director | 15,600 0.0184% | $73.01 | $1.14M | -5.6% | |
| 2026-03-16 | Sale | CG Oncology, Inc. Common stock CGON | director | 1,310 0.0015% | $63.50 | $83,185 | +4.28% | |
| 2026-01-09 | Sale | CG Oncology, Inc. Common stock CGON | director | 11,145 0.0144% | $52.47 | $584,799 | +23.01% | |
| 2025-10-09 | Sale | CG Oncology, Inc. Common stock CGON | director | 5,903 0.0077% | $43.99 | $259,673 | +42.38% | |
| 2025-09-29 | Sale | CG Oncology, Inc. Common stock CGON | director | 12,755 0.0168% | $39.19 | $499,868 | +58.34% | |
| 2025-09-19 | Sale | CG Oncology, Inc. Common stock CGON | director | 3,574 0.005% | $38.99 | $139,350 | +63.93% | |
| 2025-09-18 | Sale | CG Oncology, Inc. Common stock CGON | director | 19,112 0.0252% | $39.01 | $745,559 | +55.67% | |
| 2025-09-05 | Sale | CG Oncology, Inc. Common stock CGON | director | 27,015 0.0338% | $31.53 | $851,797 | +74.66% |